Analgesics
Antiandrogens
Antihistamines
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
TMPRSS2 inh.
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchAlkalinizationAlkalinization (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta

 

Efficacy and safety of nebulized Sodium Bicarbonate in adults with COVID-19 (SODIC): a randomized, single center, double-blinded, controlled trial

El-Badrawy et al., Current Therapeutic Research, doi:10.1016/j.curtheres.2025.100801, SODIC, NCT05035524, Nov 2022 (preprint)
https://c19early.org/elbadrawy.html
Mortality 23% Improvement Relative Risk Mortality, exc. critical 55% Mortality, moderate 79% Mortality, severe 53% Mortality, critical -23% Recovery time 28% CT score, day 30 33% CT score, day 60 100% Alkalinization  SODIC  LATE TREATMENT  DB RCT Is late treatment with alkalinization beneficial for COVID-19? Double-blind RCT 546 patients in Egypt (September 2021 - April 2022) Faster recovery with alkalinization (p<0.000001) Lower mortality for non-critical patients (p=0.02) c19early.org El-Badrawy et al., Current Therapeutic.., Nov 2022 Favorsalkalinization Favorscontrol 0 0.5 1 1.5 2+
30th treatment shown to reduce risk in November 2021, now with p = 0.0000000039 from 14 studies.
No treatment is 100% effective. Protocols combine treatments.
5,700+ studies for 169 treatments. c19early.org
RCT 546 patients showing significantly faster recovery and lower mortality with sodium bicarbonate (inhaled and nasal drops). The reduction in mortality is only statistically significant when excluding baseline critical cases. Authors hypothesize that treatment raises endosomal pH, potentially preventing SARS-CoV-2 attachment and entry into host cells.
Inhalation of nebulized sodium bicarbonate 8.4% (5ml every 4h) 7:00am to 23:00pm every day for 30 days together with 8.4% nasal drops 4 times daily (three drops for each nostril).
Targeted administration to the respiratory tract provides treatment directly to the typical source of initial SARS-CoV-2 infection and replication, and allows for rapid onset of action and reduced systemic side effects (early treatment may be more beneficial).
risk of death, 23.2% lower, RR 0.77, p = 0.26, treatment 32 of 272 (11.8%), control 42 of 274 (15.3%), NNT 28, all cases.
risk of death, 54.8% lower, RR 0.45, p = 0.02, treatment 12 of 247 (4.9%), control 27 of 251 (10.8%), NNT 17, mild/moderate/severe cases.
risk of death, 79.2% lower, RR 0.21, p = 0.21, treatment 1 of 125 (0.8%), control 5 of 130 (3.8%), NNT 33, moderate cases.
risk of death, 53.2% lower, RR 0.47, p = 0.02, treatment 11 of 63 (17.5%), control 22 of 59 (37.3%), NNT 5.0, severe cases.
risk of death, 22.7% higher, RR 1.23, p = 0.33, treatment 20 of 25 (80.0%), control 15 of 23 (65.2%), critical cases.
recovery time, 27.6% lower, relative time 0.72, p < 0.001, treatment mean 4.2 (±2.5) n=272, control mean 5.8 (±3.1) n=274, time to clinical improvement.
CT score, 33.3% lower, RR 0.67, p = 0.001, treatment 238, control 229, CT score, day 30.
CT score, 100% lower, RR < 0.001, p < 0.001, treatment 238, control 229, CT score, day 60.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
El-Badrawy et al., 18 Nov 2022, Double Blind Randomized Controlled Trial, placebo-controlled, Egypt, peer-reviewed, 8 authors, study period 2 September, 2021 - 30 April, 2022, trial NCT05035524 (history) (SODIC). Contact: dribrahim_badr@yahoo.com.
Efficacy and safety of nebulized Sodium Bicarbonate in adults with COVID-19 (SODIC): a randomized, single center, double-blinded, controlled trial
Prof Khairy Mohammad, MD El-Badrawy, Ass. Prof Ahmad Rehab, MD Elmorsey, Dr Mahmoud Mostafa Elhosiny, Dr\ Mohammed Shehta, Prof Ali Tamer, MD El-Hadidy, Dr\ Ibrahim El-Said Abdelwahab, Prof\ Adel El-Badrawy, Prof A Ahmed, MD Shokeir, Prof\ Mohammad, Khairy El-Badrawy, MD Ass Prof\, Rehab Ahmad Elmorsey, MD, Dr\ Mahmoud Mostafa Elhosiny, MD Prof\ Tamer, Ali El-Hadidy, Prof\ Ahmed A Shokeir
doi:10.1016/j.curtheres.2025.100801Reference:CUTHRE100801
Adjuvant Sodium Bicarbonate in Covid-19 treatment.
Declarations: Ethics approval and consent to participate: The study was approved by the IRB (Institutional Research Board) of Mansoura Faculty of Medicine (code number: R.21.07.1376). Competing interests: Not applicable. Authors Declaration of interests ☐ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. ☒ The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Mahmoud Mostafa Elhosiny Abolmagd reports a relationship with Mansoura University Faculty of Medicine that includes: employment. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
Abdullah, Myers, Basu, Decreased severity of disease during the first global omicron variant COVID-19 outbreak in a large hospital in tshwane, South Africa, Int J Infect Dis
Bayati, Kumar, Francis, SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis, J. Biol. Chem
Becher, Goldman, Schacham, D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients, Eur J Case Rep Intern Med
Bernheim, Mei, Huang, Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection, Radiology
Blaess, Kaiser, Sauer, COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks, Int J Mol Sci
El-Badrawy, Arram, Abdalla, Effect of adding inhalation of sodium bicarbonate 8•4% to the usual treatment on smear-positive pulmonary tuberculosis: a prospective controlled study, Egypt J Bronchol
El-Badrawy, Elela, Yousef, Effect of sodium bicarbonate 8•4% on respiratory tract pathogens, Chest Lung Res
El-Badrawy, Saleh, El-Badrawy, Role of sodium bicarbonate as adjuvant treatment of nonsevere computed tomography-identified COVID-19 pneumonia: A preliminary report, Indian J Respir Care
Francone, Iafrate, Masci, Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis, Eur Radiol
Griffin, Brennan-Rieder, Ngo, The Importance of Understanding the Stages of COVID-19 in Treatment and Trials, AIDS Rev
Han, Fan, Alwalid, Six-month follow-up chest CT findings after severe COVID-19 pneumonia, Radiology
Hasan, Capstick, Ahmed, Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis, Expert Rev Respir med
Hsu, Stone, Logan-Sinclair, Coughing frequency in patients with persistent cough: assessment using a 24-hour ambulatory recorder, Eur Respir J
Jackson, Farzan, Chen, Mechanisms of SARS-CoV-2 entry into cells, Nat Rev Mol Cell Biol
Jimenez, Codo, Sampaio, Acid pH Increases SARS-CoV-2 Infection and the Risk of Death by COVID-19, Front Med
Lechowicz, Drożdżal, Machaj, COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection, J clin med
Liu, Li, Xu, Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19, J Clin Virol
Liu, Zhang, Pan, The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study, Respir Res
Lubman, Danto, Chao, Cl (-)-HCO3-exchanger isoform AE2 is restricted to the basolateral surface of alveolar epithelial cell monolayers, Am J Respir Cell Mol Biol
Masoud, Elassal, Hassany, Management Protocol for COVID-19 Patients. Ministry of Health and Population (MOHP), Protocol for COVID
Menni, Valdes, Polidori, Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study, Lancet
Moratto, Chiarini, Giustini, Flow cytometry identifies risk factors and dynamic changes in patients with COVID-19, J Clin Immunol
Mwachari, Nduba, Nguti, Validation of a new clinical scoring system for acute bronchitis, Int J Tuberc Lung Dis
Nabahati, Ebrahimpour, Tabari, Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study• Egypt, J Radiol Nucl Med
Parasher, COVID-19: Current understanding of its pathophysiology, clinical presentation, and treatment, Postgrad med J
Rezaei, Marjani, Mahmoudi, Dynamic changes of lymphocyte subsets in the course of COVID-19, Int Arch Allergy Immunol
Rohilla, Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19, Drug dev res
Sahu, Kampa, Padhi, C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection, Clin Chim Acta
Samprathi, Jayashree, Biomarkers in COVID-19: an up-to-date review, Front Pediatr
Sharifpour, Rangaraju, Liu, COVID-19 Quality & Clinical Research Collaborative• C-Reactive protein as a prognostic indicator in hospitalised patients with COVID-19, PLoS ONE
Sigal, Jassat, Estimating disease severity of Omicron and Delta SARS-CoV-2 infections, Nat Rev Immunol
Sundh, Janson, Lisspers, The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD, Prim Care Respir J
Tang, Bidon, Jaimes, Coronavirus membrane fusion mechanism offers a potential target for antiviral development, Antiviral res
Thoracic, ATS/ACCP statement on cardiopulmonary exercise testing, Am J Respir Crit Care Med
Xu, Dong, An, Clinical and Computed Tomographic Imaging Features of Novel Coronavirus Pneumonia Caused by SARS-CoV-2, J• Infect
Zg, Zewotir, Mortality-related risk factors of COVID-19: a systematic review and metaanalysis of 42 studies and 423,117 patients, BMC Infect Dis
DOI record: { "DOI": "10.1016/j.curtheres.2025.100801", "ISSN": [ "0011-393X" ], "URL": "http://dx.doi.org/10.1016/j.curtheres.2025.100801", "alternative-id": [ "S0011393X25000268" ], "article-number": "100801", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Efficacy and safety of nebulized Sodium Bicarbonate in adults with COVID-19 (SODIC): a randomized, single center, double-blinded, controlled trial" }, { "label": "Journal Title", "name": "journaltitle", "value": "Current Therapeutic Research" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.curtheres.2025.100801" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2025 The Author(s). Published by Elsevier Inc." } ], "author": [ { "affiliation": [], "family": "El-Badrawy", "given": "Prof. Mohammad Khairy", "sequence": "first" }, { "affiliation": [], "family": "Elmorsey", "given": "Ass. Prof. Rehab Ahmad", "sequence": "additional" }, { "affiliation": [], "family": "Elhosiny", "given": "Dr. Mahmoud Mostafa", "sequence": "additional" }, { "affiliation": [], "family": "Shehta", "given": "Dr. Mohammed", "sequence": "additional" }, { "affiliation": [], "family": "El-Hadidy", "given": "Prof. Tamer Ali", "sequence": "additional" }, { "affiliation": [], "family": "Abdelwahab", "given": "Dr. Ibrahim El-Said", "sequence": "additional" }, { "affiliation": [], "family": "El-Badrawy", "given": "Prof. Adel", "sequence": "additional" }, { "affiliation": [], "family": "Shokeir", "given": "Prof. Ahmed A.", "sequence": "additional" } ], "container-title": "Current Therapeutic Research", "container-title-short": "Current Therapeutic Research", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.fr", "clinicalkey.jp", "clinicalkey.com.au", "clinicalkey.es", "clinicalkey.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2025, 5, 22 ] ], "date-time": "2025-05-22T15:48:32Z", "timestamp": 1747928912000 }, "deposited": { "date-parts": [ [ 2025, 5, 22 ] ], "date-time": "2025-05-22T15:48:37Z", "timestamp": 1747928917000 }, "indexed": { "date-parts": [ [ 2025, 5, 23 ] ], "date-time": "2025-05-23T04:20:37Z", "timestamp": 1747974037041, "version": "3.41.0" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025, 5 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 5, 1 ] ], "date-time": "2025-05-01T00:00:00Z", "timestamp": 1746057600000 } }, { "URL": "https://www.elsevier.com/legal/tdmrep-license", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 5, 1 ] ], "date-time": "2025-05-01T00:00:00Z", "timestamp": 1746057600000 } }, { "URL": "http://creativecommons.org/licenses/by-nc/4.0/", "content-version": "vor", "delay-in-days": 18, "start": { "date-parts": [ [ 2025, 5, 19 ] ], "date-time": "2025-05-19T00:00:00Z", "timestamp": 1747612800000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0011393X25000268?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0011393X25000268?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "100801", "prefix": "10.1016", "published": { "date-parts": [ [ 2025, 5 ] ] }, "published-print": { "date-parts": [ [ 2025, 5 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.1016/j.jbc.2021.100306", "article-title": "SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis", "author": "Bayati", "doi-asserted-by": "crossref", "journal-title": "J. Biol. Chem", "key": "10.1016/j.curtheres.2025.100801_bib0002", "volume": "296", "year": "2021" }, { "DOI": "10.1038/s41580-021-00418-x", "article-title": "Mechanisms of SARS-CoV-2 entry into cells", "author": "Jackson", "doi-asserted-by": "crossref", "first-page": "3", "journal-title": "Nat Rev Mol Cell Biol", "key": "10.1016/j.curtheres.2025.100801_bib0003", "volume": "23", "year": "2022" }, { "DOI": "10.3390/ijms21144953", "article-title": "COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks", "author": "Blaess", "doi-asserted-by": "crossref", "first-page": "4953", "issue": "14", "journal-title": "Int J Mol Sci", "key": "10.1016/j.curtheres.2025.100801_bib0004", "volume": "21", "year": "2020" }, { "DOI": "10.1002/ddr.21720", "article-title": "Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19", "author": "Rohilla", "doi-asserted-by": "crossref", "first-page": "12", "issue": "1", "journal-title": "Drug dev res", "key": "10.1016/j.curtheres.2025.100801_bib0005", "volume": "82", "year": "2021" }, { "DOI": "10.1016/j.antiviral.2020.104792", "article-title": "Coronavirus membrane fusion mechanism offers a potential target for antiviral development", "author": "Tang", "doi-asserted-by": "crossref", "journal-title": "Antiviral res", "key": "10.1016/j.curtheres.2025.100801_bib0006", "volume": "178", "year": "2020" }, { "DOI": "10.4103/ijrc.ijrc_48_21", "article-title": "Role of sodium bicarbonate as adjuvant treatment of non-severe computed tomography-identified COVID-19 pneumonia: A preliminary report", "author": "El-Badrawy", "doi-asserted-by": "crossref", "first-page": "318", "issue": "3", "journal-title": "Indian J Respir Care", "key": "10.1016/j.curtheres.2025.100801_bib0007", "volume": "10", "year": "2021" }, { "article-title": "Management Protocol for COVID-19 Patients", "author": "Masoud", "journal-title": "Ministry of Health and Population (MOHP), Egypt Protocol for COVID-19", "key": "10.1016/j.curtheres.2025.100801_bib0008", "year": "2020" }, { "DOI": "10.1148/radiol.2020200463", "article-title": "Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection", "author": "Bernheim", "doi-asserted-by": "crossref", "first-page": "685", "journal-title": "Radiology", "key": "10.1016/j.curtheres.2025.100801_bib0009", "volume": "295", "year": "2020" }, { "DOI": "10.1165/ajrcmb.12.2.7865219", "article-title": "Cl (-)-HCO3-exchanger isoform AE2 is restricted to the basolateral surface of alveolar epithelial cell monolayers", "author": "Lubman", "doi-asserted-by": "crossref", "first-page": "211", "issue": "2", "journal-title": "Am J Respir Cell Mol Biol", "key": "10.1016/j.curtheres.2025.100801_bib0010", "volume": "12", "year": "1995" }, { "article-title": "Effect of sodium bicarbonate 8·4% on respiratory tract pathogens", "author": "El-Badrawy", "first-page": "3", "issue": "1", "journal-title": "Chest Lung Res", "key": "10.1016/j.curtheres.2025.100801_bib0011", "volume": "1", "year": "2018" }, { "DOI": "10.4103/ejb.ejb_18_19", "article-title": "Effect of adding inhalation of sodium bicarbonate 8·4% to the usual treatment on smear-positive pulmonary tuberculosis: a prospective controlled study", "author": "El-Badrawy", "doi-asserted-by": "crossref", "first-page": "531", "journal-title": "Egypt J Bronchol", "key": "10.1016/j.curtheres.2025.100801_bib0012", "volume": "13", "year": "2019" }, { "DOI": "10.1183/09031936.94.07071246", "article-title": "Coughing frequency in patients with persistent cough: assessment using a 24-hour ambulatory recorder", "author": "Hsu", "doi-asserted-by": "crossref", "first-page": "1246", "journal-title": "Eur Respir J", "key": "10.1016/j.curtheres.2025.100801_bib0013", "volume": "7", "year": "1994" }, { "DOI": "10.4104/pcrj.2012.00054", "article-title": "The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD", "author": "Sundh", "doi-asserted-by": "crossref", "first-page": "295", "issue": "3", "journal-title": "Prim Care Respir J", "key": "10.1016/j.curtheres.2025.100801_bib0014", "volume": "21", "year": "2012" }, { "article-title": "Validation of a new clinical scoring system for acute bronchitis", "author": "Mwachari", "first-page": "1253", "journal-title": "Int J Tuberc Lung Dis", "key": "10.1016/j.curtheres.2025.100801_bib0015", "volume": "11", "year": "2007" }, { "article-title": "Acid pH Increases SARS-CoV-2 Infection and the Risk of Death by COVID-19", "author": "Jimenez", "journal-title": "Front Med (Lausanne)", "key": "10.1016/j.curtheres.2025.100801_bib0016", "volume": "8", "year": "2021" }, { "DOI": "10.1016/S0140-6736(22)00327-0", "article-title": "Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study", "author": "Menni", "doi-asserted-by": "crossref", "first-page": "1618", "journal-title": "Lancet", "key": "10.1016/j.curtheres.2025.100801_bib0017", "volume": "399", "year": "2022" }, { "DOI": "10.1136/postgradmedj-2020-138577", "article-title": "COVID-19: Current understanding of its pathophysiology, clinical presentation, and treatment", "author": "Parasher", "doi-asserted-by": "crossref", "first-page": "312", "issue": "1147", "journal-title": "Postgrad med J", "key": "10.1016/j.curtheres.2025.100801_bib0018", "volume": "97", "year": "2021" }, { "DOI": "10.1038/s41577-022-00720-5", "article-title": "Estimating disease severity of Omicron and Delta SARS-CoV-2 infections", "author": "Sigal", "doi-asserted-by": "crossref", "first-page": "267", "journal-title": "Nat Rev Immunol", "key": "10.1016/j.curtheres.2025.100801_bib0019", "volume": "22", "year": "2022" }, { "DOI": "10.1016/j.ijid.2021.12.357", "article-title": "Decreased severity of disease during the first global omicron variant COVID-19 outbreak in a large hospital in tshwane, South Africa", "author": "Abdullah", "doi-asserted-by": "crossref", "first-page": "38", "journal-title": "Int J Infect Dis", "key": "10.1016/j.curtheres.2025.100801_bib0020", "volume": "116", "year": "2021" }, { "DOI": "10.24875/AIDSRev.200001261", "article-title": "The Importance of Understanding the Stages of COVID-19 in Treatment and Trials", "author": "Griffin", "doi-asserted-by": "crossref", "first-page": "40", "issue": "1", "journal-title": "AIDS Rev", "key": "10.1016/j.curtheres.2025.100801_bib0021", "volume": "23", "year": "2021" }, { "DOI": "10.1080/17476348.2020.1804365", "article-title": "Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis", "author": "Hasan", "doi-asserted-by": "crossref", "first-page": "1149", "issue": "11", "journal-title": "Expert Rev Respir med", "key": "10.1016/j.curtheres.2025.100801_bib0022", "volume": "14", "year": "2020" }, { "DOI": "10.1164/rccm.167.2.211", "article-title": "ATS/ACCP statement on cardiopulmonary exercise testing", "doi-asserted-by": "crossref", "first-page": "211", "issue": "2", "journal-title": "Am J Respir Crit Care Med", "key": "10.1016/j.curtheres.2025.100801_bib0023", "volume": "167", "year": "2003" }, { "DOI": "10.1186/s12879-021-06536-3", "article-title": "Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients", "author": "Dessie", "doi-asserted-by": "crossref", "first-page": "855", "issue": "1", "journal-title": "BMC Infect Dis", "key": "10.1016/j.curtheres.2025.100801_bib0024", "volume": "21", "year": "2021" }, { "article-title": "D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients", "author": "Becher", "issue": "6", "journal-title": "Eur J Case Rep Intern Med", "key": "10.1016/j.curtheres.2025.100801_bib0025", "volume": "7", "year": "2020" }, { "DOI": "10.3389/fped.2020.607647", "article-title": "Biomarkers in COVID-19: an up-to-date review", "author": "Samprathi", "doi-asserted-by": "crossref", "journal-title": "Front Pediatr", "key": "10.1016/j.curtheres.2025.100801_bib0026", "volume": "8", "year": "2021" }, { "DOI": "10.1371/journal.pone.0242400", "article-title": "COVID-19 Quality & Clinical Research Collaborative C-Reactive protein as a prognostic indicator in hospitalised patients with COVID-19", "author": "Sharifpour", "doi-asserted-by": "crossref", "issue": "11", "journal-title": "PLoS ONE", "key": "10.1016/j.curtheres.2025.100801_bib0027", "volume": "15", "year": "2020" }, { "DOI": "10.1016/j.jcv.2020.104370", "article-title": "Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19", "author": "Liu", "doi-asserted-by": "crossref", "journal-title": "J Clin Virol", "key": "10.1016/j.curtheres.2025.100801_bib0028", "volume": "127", "year": "2020" }, { "DOI": "10.1016/j.cca.2020.06.013", "article-title": "C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection", "author": "Sahu", "doi-asserted-by": "crossref", "first-page": "91", "journal-title": "Clin Chim Acta", "key": "10.1016/j.curtheres.2025.100801_bib0029", "volume": "509", "year": "2020" }, { "DOI": "10.1007/s10875-020-00806-6", "article-title": "Flow cytometry identifies risk factors and dynamic changes in patients with COVID-19", "author": "Moratto", "doi-asserted-by": "crossref", "first-page": "970", "issue": "7", "journal-title": "J Clin Immunol", "key": "10.1016/j.curtheres.2025.100801_bib0030", "volume": "40", "year": "2020" }, { "DOI": "10.1159/000514202", "article-title": "Dynamic changes of lymphocyte subsets in the course of COVID-19", "author": "Rezaei", "doi-asserted-by": "crossref", "first-page": "254", "issue": "3", "journal-title": "Int Arch Allergy Immunol", "key": "10.1016/j.curtheres.2025.100801_bib0031", "volume": "182", "year": "2021" }, { "DOI": "10.1007/s00330-020-07033-y", "article-title": "Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis", "author": "Francone", "doi-asserted-by": "crossref", "first-page": "6808", "issue": "12", "journal-title": "Eur Radiol", "key": "10.1016/j.curtheres.2025.100801_bib0032", "volume": "30", "year": "2020" }, { "DOI": "10.1186/s12931-020-01385-1", "article-title": "The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study", "author": "Liu", "doi-asserted-by": "crossref", "first-page": "125", "issue": "1", "journal-title": "Respir Res", "key": "10.1016/j.curtheres.2025.100801_bib0033", "volume": "21", "year": "2020" }, { "DOI": "10.1016/j.jinf.2020.02.017", "article-title": "Clinical and Computed Tomographic Imaging Features of Novel Coronavirus Pneumonia Caused by SARS-CoV-2", "author": "Xu", "doi-asserted-by": "crossref", "first-page": "394", "journal-title": "J Infect", "key": "10.1016/j.curtheres.2025.100801_bib0034", "volume": "80", "year": "2020" }, { "DOI": "10.3390/jcm9061917", "article-title": "COVID-19: the potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection", "author": "Lechowicz", "doi-asserted-by": "crossref", "first-page": "1917", "issue": "6", "journal-title": "J clin med", "key": "10.1016/j.curtheres.2025.100801_bib0035", "volume": "9", "year": "2020" }, { "DOI": "10.1148/radiol.2021203153", "article-title": "Six-month follow-up chest CT findings after severe COVID-19 pneumonia", "author": "Han", "doi-asserted-by": "crossref", "first-page": "E177", "issue": "1", "journal-title": "Radiology", "key": "10.1016/j.curtheres.2025.100801_bib0036", "volume": "299", "year": "2021" }, { "DOI": "10.1186/s43055-021-00632-9", "article-title": "Post-COVID-19 pulmonary fibrosis and its predictive factors: a prospective study", "author": "Nabahati", "doi-asserted-by": "crossref", "first-page": "248", "journal-title": "Egypt J Radiol Nucl Med", "key": "10.1016/j.curtheres.2025.100801_bib0037", "volume": "52", "year": "2021" } ], "reference-count": 36, "references-count": 36, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0011393X25000268" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Efficacy and safety of nebulized Sodium Bicarbonate in adults with COVID-19 (SODIC): a randomized, single center, double-blinded, controlled trial", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy" }
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit